| 2026-04-06 |
KFUN148316008534 |
LEADING PHARMA LLC |
14821.0 kg |
392330.0
|
NYSTATIN ORAL SUSPENSION MU/ML, USP (ML) |
| 2026-03-28 |
EMUIMU25S0046034 |
LEADING PHARMA LLC |
14804.0 kg |
330690.0
|
NYSTATIN ORAL SUSPENSION MU/ML, USP HS COD E |
| 2026-03-28 |
EMUIMU25S0046011 |
LEADING PHARMA LLC |
14812.0 kg |
392330.0
|
NYSTATIN ORAL SUSPENSION MU/ML, USP (ML ) HS CODE |
| 2026-03-11 |
KFUN148316008020 |
LEADING PHARMA LLC |
11793.0 kg |
330690.0
|
NYSTATIN ORAL SUSPENSION MU/ML, USP |
| 2026-03-11 |
KFUN148316008022 |
LEADING PHARMA LLC |
8680.0 kg |
330690.0
|
NYSTATIN ORAL SUSPENSION MU/ML, USP |
| 2026-03-09 |
IGLBMU31000NHNYC |
LEADING PHARMA 26B MADISON |
29639.0 kg |
330690.0
|
TOTAL BOXES PACKED ON PALLETSNYSTATIN ORAL SUSPENSION MUML,USP ML TOTAL BOXES PACKED ON PALLETSNYSTATIN ORAL |
| 2026-03-01 |
SWQKSLPLUS252001 |
LEADING PHARMA LLC |
12009.0 kg |
392330.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MU/ML , USP (ML) NYSTATIN ORAL SUSPENSION MU/ ML, USP (ML) HS CODE |
| 2026-03-01 |
SWQKSLPLUS252002 |
LEADING PHARMA LLC |
8300.0 kg |
392330.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MU/ML , USP (ML) HS CODE |
| 2026-02-15 |
KFUN148316007596 |
LEADING PHARMA LLC |
29639.0 kg |
330690.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MEDICAMENTS NYSTATIN ORAL SUSPENSION |
| 2026-02-15 |
IGLBMU30835NHNYC |
LEADING PHARMA 26B MADISON |
14948.0 kg |
330690.0
|
TOTAL BOXES PACKED ON PACKAGES NYSTAT IN ORAL SUSPENSION MUML, USP ML |
| 2026-02-15 |
IGLBMU30838NHNYC |
LEADING PHARMA 26B MADISON |
14923.0 kg |
330690.0
|
TOTAL BOXES PACKED ON PACKAGES NYSTAT IN ORAL SUSPENSION MUML, USP ML |
| 2026-01-08 |
IGLBMU30043NHNYC |
LEADING PHARMA 26B MADISON |
18972.0 kg |
291229.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MUML, USP ML MUML,USP ML B.NO.C ITEM NUM BERNDC NO: - - B.NO.C ITEM NUMB ERNDC NO. - - MEDICAMENTS NYSTATIN ORALSUSPENSION MUML,US P ML MUML,USP MLB.NO.C ITEM NUMBERND C NO: B.NO.C ITEM NUMBERNDCNO. |
| 2026-01-04 |
IGLBMU30396NHNYC |
LEADING PHARMA 26B MADISON |
11272.0 kg |
330690.0
|
TOTAL BOXES ADJUSTED IN PALLETS MEDIC AMENTS NYSTATIN ORAL SUSPENSION MUML,USP ML B.NO. C NYSTATIN ORAL SUSPENSION MUML,USP ML |
| 2026-01-03 |
MPRGMUMNYK8806 |
LEADING PHARMA LLC |
14812.0 kg |
392330.0
|
HS CODE . NYSTATIN ORAL SUSPENSION MU/ML, USP ML THE TEMPERATURE TO BE SET A T DEGREE CELCIUS |
| 2026-01-03 |
KFUN148315015682 |
LEADING PHARMA LLC |
23429.0 kg |
330690.0
|
NYSTATIN ORAL SUSPENSION NYSTATIN ORAL SUSPENSION |
| 2025-12-15 |
IGLBMU30279NHNYC |
LEADING PHARMA 26B MADISON |
14159.0 kg |
330690.0
|
TOTAL BOXES ADJUSTED IN PALLETS MEDIC AMENTS NYSTATIN ORAL SUSPENSION MUML, USP ML B.NO. C |
| 2025-12-09 |
KFUN148315015012 |
LEADING PHARMA LLC |
29515.0 kg |
330690.0
|
NYSTATIN ORAL SUSPENSION NYSTATIN ORAL SUSPENSION |
| 2025-12-09 |
SULPTHN011229NYC |
LEADING PHARMA LLC |
14824.0 kg |
392330.0
|
TOTAL BOXES PACKED ON PACKAGES MEDICA MENTS - NYSTATIN ORAL SUSPENSION USP U NITS PER ML ML BOTTLES HS CODE: TEMPERATURE TO BE SET AT C |
| 2025-11-25 |
SWQKSLPLUS251803 |
LEADING PHARMA LLC |
11696.0 kg |
392330.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MU/ML , USP ( ML) HS CODE |
| 2025-11-25 |
ULPDMUM25HS00455 |
LEADING PHARMA LLC |
8680.0 kg |
293627.0
|
X FCL REEFER STC TOTAL BOXES ADJUSTED IN PACKAGES MEDICAMENTS NYSTATIN ORAL SUSPENSION MU ML, USP ( ML) B.NO.C ITEM NUMBER NDC NO: - - INVOICE NO. MPL EXP C - DTD. . . HS CODE. TEMPERATURE . C FREIGHT PREPAID |
| 2025-10-11 |
SULPTHN010969NYC |
LEADING PHARMA LLC |
8477.0 kg |
330690.0
|
TOTAL BOXES PACKED ON PACKAGES MEDICAM ENTS NYSTATIN ORAL SUSPENSION MUML, USP ML INVOICE NO DTD. . . HS CO DE: TEMPERATURE TO BE SET AT . C |
| 2025-10-06 |
KFUN148315013500 |
LEADING PHARMA LLC |
14774.0 kg |
330690.0
|
NYSTATIN ORAL SUSPENSION |
| 2025-09-23 |
IGLBMU29496NHNYC |
LEADING PHARMA 26B MADISON |
16147.0 kg |
846249.0
|
BOXES ADJUSTED IN PALLETS MEDICAMENT S NYSTATIN ORAL SUSPENSION MUML,USP B.N O.C , C ITEM NUMBERNDC NO: - - HS CODE. |
| 2025-09-10 |
YASVBOM0074392 |
KANCHAN HEALTHCARE INC |
18520.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY PHARMACEUTICAL COMMODITY |
| 2025-09-10 |
YASVBOM0074426 |
KANCHAN HEALTHCARE INC |
1648.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-09-04 |
SWQKSLPLUS251538 |
LEADING PHARMA LLC |
10092.0 kg |
392330.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MU/ML , USP ( ML) NYSTATIN ORAL SUSPENSION MU/M L, USP ( ML) HS CODE |
| 2025-09-04 |
SWQKSLPLUS251548 |
LEADING PHARMA LLC |
14492.0 kg |
392330.0
|
MEDICAMENTS NYSTATIN ORAL SUSPENSION MU/ML , USP ( ML) HS CODE |
| 2025-08-16 |
KFUN148315011958 |
LEADING PHARMA LLC |
14899.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-08-16 |
KFUN148315011959 |
LEADING PHARMA LLC |
6885.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-07-24 |
FCPWPNQS00533 |
LEADING PHARMA LLC |
10889.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION 100MU/ML, USP (473ML |
| 2025-07-09 |
SULPTHN010466NYC |
LEADING PHARMA LLC |
13335.0 kg |
300490
|
TOTAL 1991 BOXES PACKED ON 40 PACKAGES MEDICAMENTS- NYSTATIN ORAL SUSPENSION 100MUML, USP 60ML, 473ML INVOICE NO: 2932250032 DT. 26.05.2025 HS CODE: 30049099 NET WT: 11008.57 KGS |
| 2025-07-01 |
KFUN148315010967 |
LEADING PHARMA LLC |
14650.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-06-30 |
SULPTHN010425NYC |
LEADING PHARMA LLC |
8802.0 kg |
300490
|
TOTAL 2150 BOXES PACKED ON 40 PACKAGES MEDICAMENTS - NYSTATIN ORAL SUSPENSION USP 100000 UNITS PER ML 60 ML BOTTLES HS CODE: 30049099 |
| 2025-06-08 |
KFUN148315010591 |
LEADING PHARMA LLC |
14658.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-05-28 |
KFUN148315010072 |
LEADING PHARMA LLC |
14899.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-05-14 |
SIFKSMUM138020 |
LEADING PHARMA LLC |
11968.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION100MU/ML, USP (60ML)NYSTATIN ORAL SUSPENSION100MU/ML, USP (473ML) |
| 2025-05-14 |
SIFKSMUM137803 |
LEADING PHARMA LLC |
8680.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-05-14 |
SIFKSMUM138019 |
LEADING PHARMA LLC |
14915.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION 100MU/ML, USP (473ML) |
| 2025-04-17 |
MEDUVO846269 |
LEADING PHARMA LLC |
8782.0 kg |
200921
|
TOTAL 1173 BOXES PACKED ON 20 PALLETS LACOSAMIDE ORAL SOLN USP10MG/ML(200ML)US ITEM NUMBER/NDC NO:-69315-318-20 INVOICE NO. 2932240183 DTD.27.02.2025 SB NO : 8883835 DT:10.03.2025 NET WT. :7420.400KGS THE TEMPERATURE TO BE SET AT +20 DEGREE CELCIUS IN ACC |
| 2025-04-01 |
MEDUVO435618 |
LEADING PHARMA LLC |
14873.0 kg |
300490
|
01 X 40 REEFER FCL CONTAINER CONTAIN TOTAL 1 717 BOXES PACKED ON 36 PALLETS NYSTATIN ORAL SUSPENSION 100MU/ML, USP (473ML) INVOICE NO. 2932240174 DTD.03.02.2025 HS CODE : 3004906 9 SB NO : 7986194 DT: 07/02/2025 TOTAL GROSS WT : 14873.350 KGS TOTAL NET WT |
| 2025-04-01 |
MEDUVO435469 |
LEADING PHARMA LLC |
14914.0 kg |
300490
|
01 X 40 REEFER FCL CONTAINER TOTAL 1722 BOXE S PACKED ON 36 PALLETS NYSTATIN ORAL SUSPENSION 100MU/ML, USP (473ML) INVOICE NO. 2932240173 DTD.03.02.2025 HS CODE : 30049069 SB NO : 7986585 DT: 07/02/2025. TOTAL GROSS WT : 14914.770 KGS TOTAL NET WT : 12990 |
| 2025-03-11 |
KFUN148315007882 |
LEADING PHARMA LLC |
12006.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-03-11 |
KFUN148315007884 |
LEADING PHARMA LLC |
8680.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-02-15 |
SWQKSLPLUS240882 |
LEADING PHARMA LLC |
14898.0 kg |
300490
|
HS CODE 30049099 MEDICAMENTS NYSTATIN ORAL SUSPENSION |
| 2025-02-15 |
PGSMNSPNYK211818 |
LEADING PHARMA LLC |
11804.0 kg |
300490
|
NYSTATIN ORAL SUSPENSION 100MU/ML, USP (60ML)NYSTATIN ORAL SUSPENSION 100MU/ML, USP (473M L) HS CODE 30049069 |
| 2025-02-15 |
PGSMNSPNYK211817 |
LEADING PHARMA LLC |
8680.0 kg |
300490
|
HS CODE 30049069 NYSTATIN ORAL SUSPENSION 10 0MU/ML, USP (60ML) |
| 2025-02-15 |
SWQKSLPLUS240881 |
LEADING PHARMA LLC |
14882.0 kg |
300490
|
HS CODE 30049099 MEDICAMENTS NYSTATIN ORAL SUSPENSION |
| 2025-01-05 |
KFUN148314013609 |
LEADING PHARMA LLC |
14210.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-01-05 |
KFUN148314013607 |
LEADING PHARMA LLC |
12569.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |
| 2025-01-05 |
KFUN148314013608 |
LEADING PHARMA LLC |
8680.0 kg |
330690
|
NYSTATIN ORAL SUSPENSION |